Skip to main content
PeptiDex
  • Library
  • Stacks
  • Tools
  • Vendors
  • Blog
  • About
Start
§ Stay Current

The Peptide Brief.

Bi-weekly research updates, vendor news, and editorial analysis. No spam.

No spam. Unsubscribe anytime. We respect your inbox.

PeptiDex

The independent, evidence-based peptide research index. Trusted by researchers worldwide for unbiased education and verified sourcing.

§ Learn

  • Peptide 101
  • Library
  • Evidence Dashboard
  • Blog
  • FAQ

§ Tools

  • Cycle Planner
  • Evidence Dashboard
  • Peptide Comparison
  • Price Comparison
  • Reconstitution Calc
  • COA Analyzer

§ Source

  • Vendor Reviews
  • Amino Club Review
  • COA Library
  • Peptide Stacks

§ About

  • Our Mission
  • Editorial Policy
  • Medical Disclaimer
  • Contact
Last reviewed: May 4, 2026 · PeptiDex Editorial Team
© 2026 PeptiDex. All rights reserved.
PrivacyTermsDisclosures
Home/Library/Glutathione

Glutathione

By Dr. E. Vance, PhD
Last reviewed May 4, 2026

Also known as: GSH, L-Glutathione, Gamma-Glutamylcysteinylglycine, Reduced Glutathione

Glutathione is the body's most important natural antioxidant, studied for detoxification, immune support, skin brightening, and protecting cells from oxidative damage throughout the body.

Glutathione is the body's master antioxidant — a tripeptide (glutamate-cysteine-glycine) present in every cell. It neutralizes reactive oxygen species, regenerates vitamins C and E, supports Phase II

Antioxidant
Half-life: 2 hours
20 studies indexed
Updated: April 2026

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

§ AI Reference Summary

Glutathione (also known as GSH, L-Glutathione, Gamma-Glutamylcysteinylglycine, Reduced Glutathione) is a prominently researched experimental compound classified strictly within the Antioxidant framework. Operating primarily through advanced pharmacological pathways, its core mechanism of action is as follows: it glutathione is the body's master antioxidant — a tripeptide (glutamate-cysteine-glycine) present in every cell. It neutralizes reactive oxygen species, regenerates vitamins C and E, supports Phase II liver detoxification, and modulates immune cell function. Injectable GSH bypasses poor oral bioavailability. with a documented biological half-life of roughly 2 hours, In preclinical investigative trials and independent academic studies, researchers utilizing Glutathione have documented significant, quantifiable biological outcomes, primarily focusing on detoxification, antioxidant defense, immune support, skin brightening. Typical research protocols investigate administering 200000 to 600000mcg via subq pathways 2-3x/week. However, it is critically important to understand that while Glutathione demonstrates profound physiological potential in highly controlled laboratory settings, it remains classified strictly as a research chemical and has not been approved by the United States Food and Drug Administration (FDA) for human therapeutic, diagnostic, or dietary consumption. Independent chemical analysis via rigorous third-party Certificate of Analysis (COA) testing utilizing High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) remains the industry gold standard for verifying its base elemental stability when reconstituted appropriately in sterile bacteriostatic water.

GEO Optimized Extract210 Words (Optimal)

§ Mechanism of Action

Glutathione is the body's master antioxidant — a tripeptide (glutamate-cysteine-glycine) present in every cell. It neutralizes reactive oxygen species, regenerates vitamins C and E, supports Phase II liver detoxification, and modulates immune cell function. Injectable GSH bypasses poor oral bioavailability.

§ Primary Benefits

  1. 1Detoxification
  2. 2antioxidant defense
  3. 3immune support
  4. 4skin brightening

§ Clinical Evidence

Glutathione: overview of biosynthesis, regulation, and clinical role

Forman et al. (Mol. Aspects Med.): Comprehensive review of glutathione's role in redox signaling, detoxification, and its depletion in disease states including Parkinson's, liver disease, and cancer.

Strong

Glutathione and immune function

Dröge & Breitkreutz (Proc. Nutr. Soc.): Review demonstrating glutathione's critical role in lymphocyte proliferation, NK cell activity, and overall immune defense.

Moderate

Glutathione for skin lightening: randomized controlled trial

Weschawalit et al. (Clin. Cosmet. Investig. Dermatol.): RCT showing oral glutathione supplementation significantly reduces melanin index and improves skin elasticity and wrinkles.

Moderate

Glutathione depletion in Parkinson's disease substantia nigra

Sian et al.: Early landmark study demonstrating reduced glutathione levels as one of the earliest biochemical changes in Parkinson's disease pathology.

Strong

USP10 from Human Umbilical Cord Mesenchymal Stem Cells-Derived Extracellular Vesicles Mediates SCL7A11 Deubiquitination in Epithelial Cells: A Key to Anti-ferroptosis and Anti-fibrosis in Pulmonary Fibrosis.

A 2026 study found that extracellular vesicles from human umbilical cord mesenchymal stem cells reduced pulmonary fibrosis and ferroptosis in a mouse model. Researchers demonstrated this effect was driven by USP10-mediated deubiquitination and stabilization of the SLC7A11 protein.

Preclinical

Effects and mechanisms of NAD + on lung injury after cardiac arrest and cardiopulmonary resuscitation in swine.

A 2026 study demonstrated that NAD+ administration significantly attenuated lung injury following cardiac arrest and resuscitation in a swine model. Researchers found this effect was likely mediated by suppressing ferroptosis through the modulation of the YAP/ACSL4 signaling pathway.

Preclinical

Combating Cadmium-Induced Neurotoxicity, Oxidative Stress, and Inflammatory Pathways Using DOPA-31, a Dioxopiperidinamide Derivative in an In Vivo Zebrafish Model.

A 2026 preclinical study demonstrated that DOPA-31 mitigated cadmium-induced neurotoxicity in a zebrafish model by reducing oxidative stress and downregulating pro-inflammatory markers. Researchers found the derivative improved motor and cognitive functions while upregulating neuroprotective factors and reducing neuronal damage.

Preclinical

Vaccarin Improves Myocardial Ischemia-Reperfusion Injury by Attenuating Oxidative Stress and Ferroptosis Through Reducing NOX4-Modulated JAK2/STAT3 Pathway Activation.

In a 2026 preclinical study, researchers demonstrated that vaccarin alleviated myocardial ischemia-reperfusion injury in mouse and cellular models. The findings indicated that vaccarin suppressed oxidative stress and ferroptosis by inhibiting the NOX4-driven JAK2/STAT3 signaling pathway.

Preclinical

ZFP36L1 Enhances Microglial Ferroptosis in Ischemic Stroke by Reducing FTO-Mediated N6-Methyladenosine Demethylation of ACSL1 mRNA.

A 2026 study demonstrated that ZFP36L1 promotes microglial ferroptosis and neuroinflammation during ischemic stroke by reducing FTO mRNA stability and increasing ACSL1 expression. Researchers found that silencing ZFP36L1 successfully alleviated cerebral ischemic injury in mouse models.

Preclinical

Ferroptosis in Breast Cancer: Molecular Insights and Therapeutic Strategies.

Targeting ferroptosis exploits metabolic vulnerabilities in breast cancer subtypes and influences the tumor microenvironment, a 2026 review found. The research demonstrated that this iron-dependent cell death mechanism provides a potential strategy to address drug-resistant cancer stem cells.

Emerging

§ Safety Profile

Excellent safety profile. Used clinically for decades. IV and SubQ routes well-tolerated. Rare allergic reactions possible. May reduce effectiveness of some chemotherapy drugs — avoid during cancer treatment without oncologist approval.

See our evidence grading methodology for how we evaluate and grade peptide safety data.

§ Dosing Protocol

⚠️ For educational purposes only. Not medical advice. Consult a healthcare professional before using any peptide.

RouteSubQ
Dose Range200000–600000 mcg
Frequency2-3x/week
TimingMorning
Cycle Length4–12 weeks
BAC Water3 ml / 1500mg vial

SubQ: 200-600mg. IV push: 600-2000mg. For skin brightening, consistent dosing over 8-12 weeks is needed. Often combined with Vitamin C for synergistic antioxidant effect.

§ Pharmacokinetics

⏱️ Half-Life: 2h

Plasma concentration over time
100%50%0%0t½ = 2h

§ Expected Outcomes

Week 1

Improved energy and reduced oxidative stress markers

Weeks 2–4

Skin brightening begins; improved liver function markers

Month 2–3

Noticeable skin lightening effect; improved immune markers; better hangover recovery

Long-term

Sustained antioxidant protection; potential neuroprotective benefits

§ Adverse Effects

Side EffectIncidenceSeverity

Injection site redness

~5% of usersmild

Mild bloating (oral)

~8% of usersmild

Rare allergic reaction

<1% of usersrare

Incidence rates sourced from published clinical trial data where available; otherwise based on community research observations.

Where to Source Glutathione for Research

Finding verified, high-purity Glutathione requires rigorous COA verification. We independently evaluate vendors based on third-party HPLC testing, purity thresholds (≥98%), and batch-specific documentation.

View COA-Verified Glutathione

✓ Third-party tested·✓ US shipping·✓ COA on every batch

Disclosure: PeptiDex may earn a commission from purchases made through affiliate links. This does not affect our editorial independence or recommendations. We exclusively feature vendors that pass our strict quality verification protocols.

Reconstitution CalculatorCalculate reconstitution for Glutathione →
Compare ToolCompare Glutathione to similar peptides →

Frequently Asked Questions

Cite This Page

PeptiDex. (2026). Glutathione. PeptiDex Research Platform. https://peptidex.app/library/glutathione

For academic and research purposes.
Free Download

2026 Peptide Stack Cheat Sheet

12 stacks • exact dosages • cycle lengths • printable reference

No spam. Unsubscribe anytime.

§ Quick Reference

CategoryAntioxidant
Half-Life2 hours
RouteSubQ
Dose200000–600000 mcg
Studies20
FDAResearch Only

§ On This Page

  • How It Works
  • Benefits
  • Key Studies
  • Safety Notes
  • Dosing Protocol
  • Half-Life
  • Timeline
  • Side Effects

§ About the Author

Dr. E. Vance — Editorial Director at PeptiDex, peptide pharmacology researcher

Dr. E. Vance

Editorial Director, PeptiDex

Dr. E. Vance is the Editorial Director at PeptiDex and leads the platform's editorial division, ensuring that every published research summary meets rigorous preclinical citation standards. With a Ph.D. in Molecular Pharmacology from Columbia Univers...

View Full Profile
Last fact-checked: May 4, 2026 · PeptiDex Editorial Team
⚠ Educational only · Not medical advice · Most peptides are research-only / not FDA-approved